Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Platelet counts, safety assessed in phase I trial of LGD-4665 in healthy males

Dec. 14, 2007

Weight loss seen with taranabant in obese subjects

Dec. 14, 2007

Ono and Banyu submit Japanese approval application for sitagliptin for type 2 diabetes

Dec. 13, 2007

Cobalamin oral insulin significantly reduces glucose in preclinical study

Dec. 13, 2007

Dia-B Tech reports positive results from phase I clinical study of ISF-402 for type 2 diabetes

Dec. 13, 2007

Pooled trial data confirm eculizumab efficacy in paroxysmal nocturnal hemoglobinuria

Dec. 13, 2007

Janssen-Cilag submits MAA to the EMEA for dapoxetine for premature ejaculation

Dec. 11, 2007

Amylin and Lilly report positive results from study of Byetta for type 2 diabetes

Dec. 11, 2007

Novel antidiabetic agents disclosed in recent patent literature

Dec. 11, 2007

Karo Bio initiates phase I clinical studies of KB-3305 for type 2 diabetes

Dec. 10, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...